{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-047999","form_type":"8-K","ticker":"AIM","cik":"0000946644","company_name":"AIM ImmunoTech Inc.","filed_at":"2024-11-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.458265+00:00","generated_at":"2026-05-29T17:25:02.927630+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"AIM ImmunoTech adopts Cash Conservation Plan; independent directors paid entirely in stock","bullets":["Independent directors will receive 100% of board compensation in shares, effective immediately; no cash compensation.","Twice-monthly stock grants valued at closing price on last trading day before grant.","Previously announced CEO Thomas Equels and COO Peter Rodino agreed to reduce cash salaries by $200k and $50k, effective Sept 11, 2024.","Company encourages shareholders to vote for incumbent directors at Dec 17, 2024 annual meeting on WHITE proxy card."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-047999","json":"https://secwatch.observer/filing/0001493152-24-047999.json","markdown":"https://secwatch.observer/filing/0001493152-24-047999.md","text":"https://secwatch.observer/filing/0001493152-24-047999.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946644/000149315224047999/0001493152-24-047999-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946644/000149315224047999/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T17:25:02.927630+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}